Bristol-Myers Squibb Hits All-Time High Off FDA Approval For Expanded Use Of Opvido

By: via Benzinga
Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show. Bristol-Myers Squibb Co (NYSE: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.